Cipher Pharmaceuticals Inc (CPHRF)
6.30
-0.07
(-1.10%)
USD |
OTCM |
May 20, 12:15
Cipher Pharmaceuticals Total Liabilities (Quarterly): 6.958M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.958M |
December 31, 2023 | 5.511M |
September 30, 2023 | 12.98M |
June 30, 2023 | 10.41M |
March 31, 2023 | 9.819M |
December 31, 2022 | 9.696M |
September 30, 2022 | 12.99M |
June 30, 2022 | 14.04M |
March 31, 2022 | 13.65M |
December 31, 2021 | 12.75M |
September 30, 2021 | 9.547M |
June 30, 2021 | 11.71M |
March 31, 2021 | 12.38M |
December 31, 2020 | 11.63M |
September 30, 2020 | 13.28M |
June 30, 2020 | 14.84M |
March 31, 2020 | 14.84M |
December 31, 2019 | 18.44M |
September 30, 2019 | 21.02M |
June 30, 2019 | 25.87M |
March 31, 2019 | 28.47M |
December 31, 2018 | 30.93M |
September 30, 2018 | 29.00M |
June 30, 2018 | 36.31M |
March 31, 2018 | 28.02M |
Date | Value |
---|---|
December 31, 2017 | 39.70M |
September 30, 2017 | 37.46M |
June 30, 2017 | 38.52M |
March 31, 2017 | 63.07M |
December 31, 2016 | 58.73M |
September 30, 2016 | 57.06M |
June 30, 2016 | 59.72M |
March 31, 2016 | 57.11M |
December 31, 2015 | 55.39M |
September 30, 2015 | 51.43M |
June 30, 2015 | 53.32M |
March 31, 2015 | 11.13M |
December 31, 2014 | 12.02M |
September 30, 2014 | 10.04M |
June 30, 2014 | 10.80M |
March 31, 2014 | 11.78M |
December 31, 2013 | 15.77M |
September 30, 2013 | 10.42M |
June 30, 2013 | 10.58M |
March 31, 2013 | 10.25M |
December 31, 2012 | 9.599M |
September 30, 2012 | 10.24M |
June 30, 2012 | 9.810M |
March 31, 2012 | 5.276M |
December 31, 2011 | 5.053M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.511M
Minimum
Dec 2023
25.87M
Maximum
Jun 2019
13.12M
Average
12.87M
Median
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 11.50M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Lexaria Bioscience Corp | 0.2042M |
Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 92.55M |
Shareholders Equity (Quarterly) | 85.59M |
Current Ratio | 7.964 |